Strategies

Policies and programs that work

8 Strategies
Clear all

Consumer-directed health plans

Establish high deductible health plans paired with pre-tax medical expense accounts such as Health Reimbursement Arrangements (HRAs) or Health Savings Accounts (HSAs) and information tools
Evidence Rating:
Mixed Evidence
  • Quality of Care

Designated driver promotion programs

Encourage use of designated drivers via population-based mass media campaigns, incentive programs based in drinking establishments, and other efforts
Evidence Rating:
Insufficient Evidence
  • Alcohol and Drug Use

Financial education for adults

Provide one-on-one or group adult education programs that cover topics such as basic budgeting, bank use, credit management, bankruptcy, credit building and counseling, homeownership, retirement, divorce, etc.
Evidence Rating:
Insufficient Evidence
  • Income

Hospital wristband color standardization

Establish national standards for the colors of patient wristbands used to alert health care providers about specific conditions such as allergies or elevated fall risk
Evidence Rating:
Insufficient Evidence
  • Quality of Care

Human papillomavirus (HPV) vaccine education

Inform adolescents, young adults, and parents about HPV and its consequences, as well as the benefits of vaccination, via videos, printed materials, online content, or in-person efforts
Evidence Rating:
Insufficient Evidence
  • Sexual Activity

Mass media campaigns against underage drinking

Use television, radio, print, and social media efforts to increase awareness of underage drinking and its consequences
Evidence Rating:
Insufficient Evidence
  • Alcohol and Drug Use

Media restrictions on sexual content

Reduce child and adolescent access to sexual content in television, movies, music, and videogames via rating systems, parental advisories, parental guidelines, etc.
Evidence Rating:
Insufficient Evidence
  • Sexual Activity

Tiered drug formularies

Vary patient drug costs by tier; e.g., generic drugs have the lowest co-pay or cost sharing in tier one, then preferred brand name medications (tier two), then non-formulary drugs (tier three)
Evidence Rating:
Mixed Evidence
  • Quality of Care